What's the most recent regulatory action in Enterococcus Urinary Tract Infection?

Most recent: Monurol — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterococcus-urinary-tract-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterococcus Urinary Tract Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterococcus Urinary Tract Infection (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterococcus Urinary Tract Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Levaquin	levofloxacin	Generic (originally Daiichi Sankyo/J&J)	Fluoroquinolone Antibacterial [EPC]	CAAX prenyl protease 2, Multidrug and toxin extrusion protein 1, Potassium voltage-gated channel subfamily H member 2	1996-12-20
Monurol	FOSFOMYCIN	Zambon Spa	fosfomycin		1996-01-01
Cipro	ciprofloxacin	Bayer AG	Fluoroquinolone antibiotic	DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A	1987-10-22
Claforan	CEFOTAXIME	Sterimax	Cephalosporin Antibacterial		1981-01-01
Cefradex	cefradine	Bristol-Myers Squibb	cefradine	Matrix metalloproteinase-9	1974-01-01
Unasyn	AMPICILLIN	Bristol-Myers Squibb	Penicillin-class Antibacterial	Transient receptor potential cation channel subfamily M member 4	1965-01-01
Furacin	NITROFURAZONE	Takeda	nitrofurazone	Sterile alpha and TIR motif-containing protein 1	1945-01-01
MACRODANTIN	NITROFURANTOIN, MACROCRYSTALLINE	ALMATICA	Nitrofuran Antibacterial [EPC]	Mitochondrial pyruvate carrier 2, CDGSH iron-sulfur domain-containing protein 1, Glucose-6-phosphate 1-dehydrogenase
Ofloxacine	Ofloxacine	Assistance Publique - Hôpitaux de Paris		Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1
Cephradin	Cephradin	Sohag University		Matrix metalloproteinase-9, Somatostatin receptor type 4, Bacterial penicillin-binding protein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-04-09 — Monurol · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 6 drugs in Enterococcus Urinary Tract Infection
Bristol-Myers Squibb · 2 drugs in Enterococcus Urinary Tract Infection
Assistance Publique - Hôpitaux de Paris · 1 drug in Enterococcus Urinary Tract Infection
Bayer AG · 1 drug in Enterococcus Urinary Tract Infection
Generic (originally Daiichi Sankyo/J&J) · 1 drug in Enterococcus Urinary Tract Infection
Poitiers University Hospital · 1 drug in Enterococcus Urinary Tract Infection
Sohag University · 1 drug in Enterococcus Urinary Tract Infection
Sterimax · 1 drug in Enterococcus Urinary Tract Infection
Takeda · 1 drug in Enterococcus Urinary Tract Infection
Zambon Spa · 1 drug in Enterococcus Urinary Tract Infection
ALMATICA · 1 drug in Enterococcus Urinary Tract Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterococcus Urinary Tract Infection:

Cite this brief

Drug Landscape (2026). Enterococcus Urinary Tract Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterococcus-urinary-tract-infection. Accessed 2026-06-10.

Enterococcus Urinary Tract Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing